Last reviewed · How we verify
Vi Polysaccharide — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Vi Polysaccharide (Vi Polysaccharide) — National Institute of Allergy and Infectious Diseases (NIAID).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vi Polysaccharide TARGET | Vi Polysaccharide | National Institute of Allergy and Infectious Diseases (NIAID) | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vi Polysaccharide CI watch — RSS
- Vi Polysaccharide CI watch — Atom
- Vi Polysaccharide CI watch — JSON
- Vi Polysaccharide alone — RSS
Cite this brief
Drug Landscape (2026). Vi Polysaccharide — Competitive Intelligence Brief. https://druglandscape.com/ci/vi-polysaccharide. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab